https://ojs.acad-pub.com/index.php/N-C <p><em>Nano Carbons</em> is a prestigious open access, peer-reviewed journal that delves into the multifaceted world of nanocarbon research. It serves as a platform for scholars and researchers to share their findings and insights across a broad spectrum of topics related to nanocarbon. It publishes various article types including Original Research Articles, Reviews, Editorials, and Perspectives, all of which undergo a rigorous peer-review process to ensure the dissemination of high-quality, cutting-edge knowledge. In addition, the journal emphasizes interdisciplinary research and encourages the integration of nanocarbon with fields such as biomedicine and industry.</p> <p>&nbsp;</p> <p><em>Nano Carbons</em> is a comprehensive journal that caters to the scientific community interested in the latest advancements in nanocarbon science and technology, providing a forum for the exchange of ideas and the promotion of interdisciplinary collaboration.</p> Academic Publishing Pte. Ltd. en-US Nano Carbons 3029-2824 <p>Authors contributing to this journal agree to publish their articles under the&nbsp;<a href="http://creativecommons.org/licenses/by/4.0" target="_blank" rel="noopener">Creative Commons Attribution 4.0 International License</a>, allowing third parties to share their work (copy, distribute, transmit) and to adapt it&nbsp;<span lang="EN-US">for any purpose, even commercially, under the condition that the authors are given credit.</span>&nbsp;With this license, authors hold the copyright.</p> <p><img src="https://esp.apacsci.com/public/site/images/reviewer/OIP-C.jpg" alt=""></p> https://ojs.acad-pub.com/index.php/N-C/article/view/1254 <p>Cancer is a global health challenge, and early detection is crucial for effective treatment to improve patient outcomes. In recent years, nanomaterial-based biosensors have emerged as powerful tools for the detection of cancer biomarkers in human fluids. This article highlights the recent progress in biosensor technology for the detection of cancer biomarkers, focusing on advancements in sensitivity, selectivity, multiplexed detection, liquid biopsies, point-of-care testing, wearable biosensors, and integration with artificial intelligence (AI). Recent advancements have significantly improved the sensitivity and selectivity of biosensors, allowing for the detection of low concentrations of cancer biomarkers in complex biological samples. Novel sensing technologies, such as nanomaterial-based sensors and aptamer-based sensors, have played a crucial role in enhancing biosensor performance. Multiplexed biosensors have the ability to simultaneously detect multiple cancer biomarkers, providing comprehensive diagnostic information. This capability is particularly valuable for accurate cancer diagnosis and prognosis. Liquid biopsies, which involve the detection of cancer biomarkers in circulating tumor cells, cell-free DNA, or exosomes present in body fluids, have gained considerable attention. Biosensors have played a pivotal role in the development of liquid biopsy technologies, offering non-invasive and real-time monitoring of cancer progression, treatment response, and the emergence of drug resistance. The integration of biosensors with AI algorithms has shown great potential. AI can analyze and interpret biosensor data, identifying patterns, correlations, and biomarker signatures that may be difficult to detect with traditional methods.</p> Razu Shahazi Amirul Islam Saddam Md Rakibul Islam Mohammed Muzibur Rahman Giti Paimard Ajoy Kumer Md. Mahmud Alam Md. Kawsar Mahamud Copyright (c) 2024 Razu Shahazi, Amirul Islam Saddam, Md Rakibul Islam, Mohammed Muzibur Rahman, Giti Paimard, Ajoy Kumer, Md. Mahmud Alam, Md. Kawsar Mahamud https://creativecommons.org/licenses/by/4.0/ 2024-07-18 2024-07-18 2 2 1254 1254 10.59400/n-c.v2i2.1254